Clinical applications of tacrolimus in the treatment of ocular diseases: a narrative literature review
Tacrolimus is a practical steroid‑sparing therapy for severe ocular surface inflammation. Priority trials should be formulation‑specific with standardized outcomes and pharmacokinetic endpoints, alongside pediatric safety registries and head‑to‑head comparisons versus cyclosporine 2% and soft steroids.
Authors
- Ali Hendi Alghamdi
Institutions
- Al Baha University (SA)
Publication Details
- Journal
- International Ophthalmology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1007/s10792-025-03844-4
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00